GlassScriptPhysician profile
Karamchand Paul
NPI 1114926383
$9,473.46
in general payments reported to CMS, 2019-2025
36 companies · $1,678 in 2025
The $1,678 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,313 · 2020: $259 · 2021: $1,030 · 2022: $1,137 · 2023: $1,673 · 2024: $2,384 · 2025: $1,678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,735.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $2,600.38 | 2023-2025 | Ffrct |
| Janssen Pharmaceuticals, INC | $994.64 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $960.68 | 2019-2025 | |
| Amgen INC. | $844.44 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $774.10 | 2019-2025 | Ekosonic, Watchman Flx |
| Pfizer INC. | $738.76 | 2019-2025 | |
| Novo Nordisk INC | $494.53 | 2019-2025 | Wegovy, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $356.76 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $299.72 | 2019-2024 | Farxiga, Brilinta |
| E.R. Squibb & Sons, L.L.C. | $171.31 | 2019-2025 | Camzyos, Eliquis |
| Sanofi-Aventis U.S. LLC | $158.63 | 2019-2023 | |
| Astellas Pharma US INC | $149.48 | 2019 | |
| Amarin Pharma, INC. | $100.26 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $83.85 | 2022-2023 | Verquvo |
| Daiichi Sankyo INC. | $69.10 | 2019-2023 | Injectafer |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $66.69 | 2022-2023 | Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $66.39 | 2019-2023 | Lifevest |
| Abiomed | $63.28 | 2019-2022 | |
| Terumo Medical Corporation | $63.06 | 2019-2023 | Glidewire |
| Lantheus Medical Imaging, INC. | $58.56 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $55.65 | 2019-2022 | |
| Cleerly, INC. | $41.69 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Gilead Sciences, INC. | $36.07 | 2019 | |
| Alnylam Pharmaceuticals INC. | $32.79 | 2023 | Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $28.18 | 2019-2025 | |
| Cordis US Corp. | $21.01 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $16.43 | 2023 | Arcalyst |
| Shockwave Medical, INC | $15.64 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Glaxosmithkline, LLC. | $15.11 | 2025 | Arexvy, Shingrix |
| Actelion Pharmaceuticals US, INC. | $15.00 | 2023 | Uptravi, Opsumit |
| Altathera Pharmaceuticals LLC | $14.55 | 2022 | |
| Avanos Medical | $14.36 | 2024 | Generator |
| Kestra Medical Technology Services, INC. | $14.28 | 2023 | Assure Wcd |
| Cvrx, INC. | $14.19 | 2023 | Barostim Neo System |
| Chiesi USA, INC. | $13.88 | 2025 | Kengreal |
| Cardiovascular Systems INC. | $10.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karamchand Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.